Newly found small-genome viruses suggest encapsulins and viruses evolved from each other repeatedly
University of Miami researchers identified previously unknown viruses that bridge viruses and encapsulin compartments in cells, Phys.org reported. The Nature Communications paper reports evidence that the two lineages evolved from one another repeatedly over millions of years. That contests the theory that encapsulins simply descended from viruses.
Reality
- Evidence55
- Adoption
- Not scored
- Hype gap+15
- Incentives
- Not scored
- Confidence45
AlphaFold predictions helped ITQB NOVA engineer a bacterial galactose oxidase
ITQB NOVA researchers engineered PsGalOx, which they call the first bacterial galactose oxidase, into a variant 40 to 1,800 times more efficient. The team says much of the gain in directed evolution came from cells making more protein; drug substrates are still ahead.
Reality
- Evidence50
- Adoption
- Not scored
- Hype gap+15
- Incentives
- Not scored
- Confidence55
Alphabet's Isomorphic Labs is in funding talks at a $40 billion valuation. Crypto Briefing put its prior mark near $17.5 billion, so the ask more than doubles the price of a drug designer that has yet to dose a patient.
Perspective Coverage
6 publishers
- Builder
- Builder 26%
- Operator
- Operator 17%
- Investor
- Investor 57%
Reality
- Evidence55
- Adoption25
- Hype gap+45
- Incentives55
- Confidence55
Two RAB1 proteins bridge the adaptor OPTN to the vesicles that seed mitophagy membranes
Tokyo Metropolitan Institute of Medical Science researchers report that RAB1A and RAB1B, two of about 60 human RAB proteins, tie OPTN to ATG9A vesicles. The link helps set where the membrane around a damaged mitochondrion begins to form, and labs can now test that step directly.
Reality
- Evidence45
- Adoption
- Not scored
- Hype gap+10
- Incentives
- Not scored
- Confidence55
AlphaGenome Atlas answers every possible one-letter question in the human genome in advance, roughly a petabyte of predictions. Noncommercial access opened Tuesday, commercial use waits on Google Cloud, and the launch write-up carries no accuracy number.
Perspective Coverage
3 publishers
- Builder
- Builder 42%
- Operator
- Operator 33%
- Investor
- Investor 25%
Reality
- Evidence62
- Adoption15
- Hype gap+25
- Incentives55
- Confidence65
Forty-four percent of surveyed scientists report their bottleneck has moved downstream to the bench
A new report combines a survey of 637 scientists with 15 million Gemini conversations. Its authors trace the gap between mathematics and biology to what it costs to check whether an answer is right.
Reality
- Evidence58
- Adoption58
- Hype gap−10
- Incentives70
- Confidence55
Apple's SimpleDesign drops the tokenizer stage from protein co-design
Apple researchers report that one end-to-end training run on more than 2 million sequence-and-structure pairs competes with the usual tokenizer-then-generator pipelines.
Reality
- Evidence45
- Adoption10
- Hype gap+15
- Incentives62
- Confidence55
GPN-Star folds whole-genome alignments and a species tree into its architecture, which is how it trains in hours where Evo 2 needed 2,000 processors and months. The cost of building those alignments sits outside that comparison.
Reality
- Evidence60
- Adoption14
- Hype gap+28
- Incentives72
- Confidence58
Academics get all 9 billion single-base predictions through a browser at no cost, while commercial users wait on a Google Cloud licence whose terms DeepMind has not published, including for its own sister company.
Reality
- Evidence54
- Adoption30
- Hype gap+24
- Incentives78
- Confidence58
ARIA puts $46M behind the protein interfaces where autism risk genes converge
Mutations in different autism genes break the same protein contact in UCSF's new Science atlas, and that observation is what ARIA is now paying $46 million to turn into a molecule. The organoid evidence sets the ceiling on what it can mean so far.
Reality
- Evidence60
- Adoption22
- Hype gap+36
- Incentives68
- Confidence52
HydroGym ships more than 60 validated environments reaching Re = 4 x 10^5, plus a proof of concept where agents trained on cheap surrogates cut local skin friction on a 3D wing section.
Reality
- Evidence70
- Adoption18
- Hype gap+27
- Incentives58
- Confidence64
buildConfirmed2 publishers The startup opened a robotic "human data center" near San Francisco on the thesis that AI drug discovery is limited by causal human experiments, not model capacity.
Reality
- Evidence44
- Adoption31
- Hype gap+24
- Incentives71
- Confidence56
Vivodyne says the AI drug bottleneck is human tissue data, not model capability
The startup opened what it calls the world's largest human data center last week. Its diagnosis of the field is testable; most of the evidence for its own machines is self-reported.
Reality
- Evidence34
- Adoption27
- Hype gap+32
- Incentives76
- Confidence44
AI antibody design clears one task in three in first blinded benchmark
AIntibody tested 511 antibodies from 29 organizations on three tasks. Ranking clones inside HCDR3 clusters was worse than random for every model but one.
Reality
- Evidence76
- Adoption38
- Hype gap+42
- Incentives55
- Confidence62
AI built a working phage genome. It still cannot tell you which phage to use
A Science paper from Stanford reports an AI-designed phage genome that produced a functioning virus. Predicting which phage infects which bacterium is still posed as an open question.
Reality
- Evidence38
- Adoption14
- Hype gap+8
- Incentives58
- Confidence42